DanielJamesDooleyMD

Cardiology • Annapolis, MD

Physician

Join to view full profile

Dr. Dooley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dooley's full profile

Already have an account?

Office
2002 Medical Parkway
Suite 500
Annapolis, MD 21401
Phone+1 410-573-6480

Education & Training

MedStar Health/Georgetown-Washington Hospital CenterFellowship, Cardiovascular Disease, 2015 - 2018
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2012 - 2015
Georgetown University School of MedicineClass of 2012

Certifications & Licensure

MD State Medical License 2018 - 2026
DC State Medical License 2015 - 2018
VA State Medical License 2012 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Publications & Presentations

PubMed

14 citations
Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.
Phillip H. Lam, Poonam Bhyan, Cherinne Arundel, Daniel J. Dooley, Helen Sheriff
Clinical Cardiology. 2018-03-01
20 citations
Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.
Phillip H. Lam, Neha Gupta, Daniel J. Dooley, Steven N. Singh, Prakash Deedwania
The American Journal of Medicine. 2018-12-01
17 citations
Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.
Phillip H. Lam, Daniel J. Dooley, Gregg C. Fonarow, Javed Butler, Deepak L. Bhatt
European Journal of Heart Failure. 2018-02-01

Press Mentions

Governor Kemp Names 18 New AppointmentsMay 26th, 2021